Recent News for TGTX - TG Therapeutics, Inc.

Date Title
Aug 12 Large Option Trader Sells TG Therapeutics Calls After Big Run
Aug 12 Edited Transcript of TGTX earnings conference call or presentation 9-Aug-19 12:30pm GMT
Aug 12 What Kind Of Shareholder Owns Most TG Therapeutics, Inc. (NASDAQ:TGTX) Stock?
Aug 9 TG Therapeutics Inc (TGTX) Q2 2019 Earnings Call Transcript
Aug 9 TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q2 2019 Results - Earnings Call Transcript
Aug 9 TG Therapeutics net loss improves in Q2
Aug 9 TG Therapeutics EPS beats by $0.02, revenue in-line
Aug 9 TG Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results
Aug 9 The Daily Biotech Pulse: Vascepa Delay Sends Amarin Reeling, Eidos Jumps On Buyout Offer, Nektar's Bitter Q2
Aug 7 TG Therapeutics to Host Conference Call on Second Quarter 2019 Financial Results and Business Update
Aug 3 29 Healthcare Stocks Moving In Friday's After-Market Session
Jul 31 Steven Cohen Charges Into Chiasma
Jul 5 Here’s What Hedge Fund Think About TG Therapeutics Inc (TGTX)
Jul 2 TG Therapeutics Announces Presentation of Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis During an Oral Session at the 5th Congress of the European Academy of Neurology
Jul 1 Weekly CEO Buys Highlight
Jun 27 Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Balance Sheet Strong Enough To Weather A Storm?
Jun 27 TG Therapeutics: Hitting A Growth Inflection
Jun 18 TG Therapeutics to Present at the Raymond James Life Sciences and MedTech Conference
Jun 17 TG Therapeutics Presents Preclinical Data for TG-1801, a First-in-Class Anti-CD47/CD19 Bispecific Antibody, at the 24th European Hematology Association Annual Congress
Jun 11 TG on go with U.S. application for umbralisib in MZL
Jun 11 TG Therapeutics Confirms Registration Path for Umbralisib in Marginal Zone Lymphoma Following FDA Meeting
Jun 5 TG up 4% on positive umbralisib data in MZL
Jun 4 TG Therapeutics Presents Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 55th American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 4 TG Therapeutics to Present at the Jefferies 2019 Healthcare Conference
Jun 1 The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace
Back to the Main TGTX Page...